Skip to main content
Clinical Trials/DRKS00003277
DRKS00003277
Completed
Not Applicable

Increasing the efficiency of depression-screening using patient-targeted feedback: Randomized controlled trial - DEPSCREEN-INFO

Bundesministerium für Bildung und Forschung Dienstsitz Berlin0 sites4,151 target enrollmentJuly 3, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
F32
Sponsor
Bundesministerium für Bildung und Forschung Dienstsitz Berlin
Enrollment
4151
Status
Completed
Last Updated
last year

Overview

Brief Summary

Background: International guidelines advocate depression screening in patients with coronary heart disease (CHD) and other chronic illnesses, but evidence is lacking. Aims: To test the differential efficacy of written patient-targeted feedback v. no written patient feedback after depression screening. Method: Patients with CHD or hypertension from three cardiology settings were randomised and screened for depression (ClinicalTrials.gov Identifier: NCT01879111). Compared with the control group, where only cardiologists received written feedback, in the intervention group both cardiologists and patients received written feedback regarding depression status. Depression severity was measured 1 month (primary outcome) and 6 months after screening. Results: The control group (n = 220) and the patient-feedback group (n = 155) did not differ in depression severity 1 month after screening. Six months after screening, the patient-feedback group showed significantly greater improvements in depression severity and was twice as likely to seek information about depression compared with the control group. Conclusions: Patient-targeted feedback in addition to screening has a significant but small effect on depression severity after 6 months and may encourage patients to take an active role in the self-management of depression.

Registry
who.int
Start Date
July 3, 2012
End Date
May 1, 2014
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Bundesministerium für Bildung und Forschung Dienstsitz Berlin

Eligibility Criteria

Inclusion Criteria

  • Attendance in a cardiac clinic;
  • Clinical diagnosis of coronary heart disease or hypertension;
  • Age \= 18 years;
  • Sufficient language skills;
  • Informed consent

Exclusion Criteria

  • Life threatening health status;
  • Severe somatic or/and psychological disorder that needs urgent treatment;
  • Acute suicidal tendency;
  • Severe cognitive or/and visual difficulties;
  • Not being able to fill out questionnaires

Outcomes

Primary Outcomes

Not specified

Similar Trials